Home Health Care News January 13, 2025
In December, word spread that Walgreens Boots Alliance Inc. (Nasdaq: WBA) was reportedly considering selling itself to the PE firm Sycamore Partners. A month later, experts believe that the heat on these talks have died down.
Though WBA struggled throughout 2024, a sale to Sycamore is now unlikely, executives indicated.
“Walgreens’ Q1 2025 earnings report solidifies that the company’s turnaround is officially underway following an incredibly difficult 2024 where it finished as the S&P’s worst-performing stock of the year,” Emarketer analyst Rajiv Leventhal told Forbes. “And CEO Tim Wentworth’s comments on being committed to a retail pharmacy-led operating model that will drive long-term value indicate that the rumored sale to PE firm Sycamore Partners is less likely.”
At Walgreens, a...
Today's Sponsors
Today's Sponsor